Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib.

Abstract

Our findings indicate that CFR is significantly impaired in cancer patients on sunitinib treatment. There is an inverse correlation between CFR and duration of sunitinib treatment and inflammation markers.